In recent years, nutraceutical companies have been upping their investment in clinical trials to improve the research, quality and science behind their product or ingredient. Leaders in the clinical trials space predict that human challenge models will be in favour over traditional human field studies, because they entail a natural exposure to pathogens and are more time effective.

Charlotte Bastiaanse, associate editor at Vitafoods Insights, talks to Alwine Kardinaal, expertise group leader of health & nutrition at NIZO, about the potential for human challenge models, why they are of interest to nutraceutical manufacturers and what production of test products in clinical trials could look like.